Postoperative Sugammadex After COVID-19
NCT05817019
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
300
Enrollment
OTHER
Sponsor class
Conditions
General Anesthesia
COVID-19
Interventions
DRUG:
Sugammadex Sodium
DRUG:
neostigmine 50µg/kg + glycopyrollate 0.01mg/kg
Sponsor
Korea University Ansan Hospital